nerolidol has been researched along with Leiomyoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, WW; Chen, SM; Dong, JR | 1 |
1 other study(ies) available for nerolidol and Leiomyoma
| Article | Year |
|---|---|
Nerolidol inhibits proliferation of leiomyoma cells via reactive oxygen species-induced DNA damage and downregulation of the ATM/Akt pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Damage; Down-Regulation; Leiomyoma; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sesquiterpenes | 2021 |